Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?

Transpl Infect Dis. 2023 Apr;25(2):e14046. doi: 10.1111/tid.14046. Epub 2023 Mar 2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antifungal Agents* / therapeutic use
  • Hematologic Neoplasms* / complications
  • Humans
  • Nitriles / therapeutic use
  • Triazoles / therapeutic use

Substances

  • Antifungal Agents
  • isavuconazole
  • Triazoles
  • Nitriles